Eli Lilly total revenue 2007-2024
This graph shows the revenue of Eli Lilly and Company from 2007 to 2024. Eli Lilly is one of the top global pharmaceutical companies. In 2024, the company generated over 45 billion U.S. dollars of revenue.
Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Eli Lilly
Market overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2025
- Premium Statistic World's most valuable pharmaceutical brands 2024 by brand value
- Premium Statistic Projection of top 2025 pharma and biotech launches by revenue 2030
Key figures
4
Business distribution
3
Competitors
4
Research and development
5
- Premium Statistic Total global pharmaceutical R&D spending 2014-2030
- Basic Statistic Eli Lilly research and development expenditure 2007-2024
- Basic Statistic Eli Lilly R&D expenditure as a share of revenue 2010-2024
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Basic Statistic Projected most valuable R&D projects based on net present value 2024
Further related statistics
18
- Eli Lilly's total revenue per employee 2013-2019
- Eli Lilly capital expenditures 2013-2024
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2023
- Dividends paid by Novartis AG 2009-2024
- Boehringer Ingelheim's number of employees 2007-2023
- Boehringer Ingelheim's income after taxes 2005-2022
- Insulin-replacement medications - revenues 2010
- Sectors with largest supply inputs on the U.S. biopharmaceutical industry 2022
- Allergan's employee number 2016-2019
- U.S. biopharmaceutics: employment by occupation
- Top U.S. market share of SNRIs based on precriptions 2013
- EBITDA of pharmaceutical company Recordati 2015-2023
- Revenue of Johnson & Johnson's consumer health segment worldwide 2012-2024
- Europe: glands and extracts import value by country 2023
- Top U.S. SNRIs based on revenue 2013
- Europe: human and animal blood preparations export value by country 2023
- API imports in India FY 2012-FY 2020
- Structure of the North American cosmeceuticals market by country 2015
Further Content: You might find this interesting as well
Statistics
- Eli Lilly's total revenue per employee 2013-2019
- Eli Lilly capital expenditures 2013-2024
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2023
- Dividends paid by Novartis AG 2009-2024
- Boehringer Ingelheim's number of employees 2007-2023
- Boehringer Ingelheim's income after taxes 2005-2022
- Insulin-replacement medications - revenues 2010
- Sectors with largest supply inputs on the U.S. biopharmaceutical industry 2022
- Allergan's employee number 2016-2019
- U.S. biopharmaceutics: employment by occupation
- Top U.S. market share of SNRIs based on precriptions 2013
- EBITDA of pharmaceutical company Recordati 2015-2023
- Revenue of Johnson & Johnson's consumer health segment worldwide 2012-2024
- Europe: glands and extracts import value by country 2023
- Top U.S. SNRIs based on revenue 2013
- Europe: human and animal blood preparations export value by country 2023
- API imports in India FY 2012-FY 2020
- Structure of the North American cosmeceuticals market by country 2015
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Eli Lilly and Company, & U.S. Securities and Exchange Commission. (February 19, 2025). Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 20, 2025, from https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/
Eli Lilly and Company, und U.S. Securities and Exchange Commission. "Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars)." Chart. February 19, 2025. Statista. Accessed April 20, 2025. https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/
Eli Lilly and Company, U.S. Securities and Exchange Commission. (2025). Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 20, 2025. https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/
Eli Lilly and Company, and U.S. Securities and Exchange Commission. "Revenue of Eli Lilly and Company from 2007 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 19 Feb 2025, https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/
Eli Lilly and Company & U.S. Securities and Exchange Commission, Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/ (last visited April 20, 2025)
Revenue of Eli Lilly and Company from 2007 to 2024 (in million U.S. dollars) [Graph], Eli Lilly and Company, & U.S. Securities and Exchange Commission, February 19, 2025. [Online]. Available: https://www.statista.com/statistics/266590/pharmaceutical-company-eli-lilly-revenue-since-2007/